Mytrus appoints Anthony Costello as CEO

Friday, July 6, 2012 01:33 PM

Mytrus, a San Francisco-based clinical technology and services company for medical and pharmaceutical research, has appointed Anthony J. Costello as CEO. He

Costello is one of the founding members of Mytrus and previously served as its COO.  Before joining the company in 2009, he co-founded Nextrials and served as its vice president of product development. Costello also served for several years as manager of oncology clinical data management at Genentech. He is a past chairman of the board of trustees for the Society of Clinical Data Management and a member of the editorial advisory board for Applied Clinical Trials magazine.

Steve Cummings, the former Mytrus CEO, now serves as the company’s new CSO and remains as chairman of the board of directors.

Share:          
CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs